Kim Kyeongkyu, Boo Kyungjin, Yu Young Suk, Oh Se Kyu, Kim Hyunkyung, Jeon Yoon, Bhin Jinhyuk, Hwang Daehee, Kim Keun Il, Lee Jun-Su, Im Seung-Soon, Yoon Seul Gi, Kim Il Yong, Seong Je Kyung, Lee Ho, Fang Sungsoon, Baek Sung Hee
Department of Biological Sciences, Creative Research Initiatives Center for Chromatin Dynamics, Seoul National University, Seoul, 08826, South Korea.
Graduate School of Cancer Science and Policy, Research Institute, National Cancer Center, Gyeonggi-do, 10408, South Korea.
Nat Commun. 2017 Jul 31;8(1):162. doi: 10.1038/s41467-017-00215-1.
The retinoic acid receptor-related orphan receptor-α (RORα) is an important regulator of various biological processes, including cerebellum development, circadian rhythm and cancer. Here, we show that hepatic RORα controls lipid homeostasis by negatively regulating transcriptional activity of peroxisome proliferators-activated receptor-γ (PPARγ) that mediates hepatic lipid metabolism. Liver-specific Rorα-deficient mice develop hepatic steatosis, obesity and insulin resistance when challenged with a high-fat diet (HFD). Global transcriptome analysis reveals that liver-specific deletion of Rorα leads to the dysregulation of PPARγ signaling and increases hepatic glucose and lipid metabolism. RORα specifically binds and recruits histone deacetylase 3 (HDAC3) to PPARγ target promoters for the transcriptional repression of PPARγ. PPARγ antagonism restores metabolic homeostasis in HFD-fed liver-specific Rorα deficient mice. Our data indicate that RORα has a pivotal role in the regulation of hepatic lipid homeostasis. Therapeutic strategies designed to modulate RORα activity may be beneficial for the treatment of metabolic disorders.Hepatic steatosis development may result from dysregulation of lipid metabolism, which is finely tuned by several transcription factors including the PPAR family. Here Kim et al. show that the nuclear receptor RORα inhibits PPARγ-mediated transcriptional activity by interacting with HDAC3 and competing for the promoters of lipogenic genes.
维甲酸受体相关孤儿受体α(RORα)是多种生物学过程的重要调节因子,包括小脑发育、昼夜节律和癌症。在此,我们表明肝脏中的RORα通过负向调节介导肝脏脂质代谢的过氧化物酶体增殖物激活受体γ(PPARγ)的转录活性来控制脂质稳态。当用高脂饮食(HFD)进行挑战时,肝脏特异性Rorα基因敲除小鼠会出现肝脏脂肪变性、肥胖和胰岛素抵抗。全转录组分析显示,肝脏特异性缺失Rorα会导致PPARγ信号失调,并增加肝脏葡萄糖和脂质代谢。RORα特异性结合并募集组蛋白去乙酰化酶3(HDAC3)至PPARγ靶启动子,以实现对PPARγ的转录抑制。PPARγ拮抗作用可恢复高脂饮食喂养的肝脏特异性Rorα基因敲除小鼠的代谢稳态。我们的数据表明,RORα在肝脏脂质稳态调节中起关键作用。旨在调节RORα活性的治疗策略可能对代谢紊乱的治疗有益。肝脏脂肪变性的发生可能源于脂质代谢失调,脂质代谢由包括PPAR家族在内的多种转录因子精细调节。在此,Kim等人表明,核受体RORα通过与HDAC3相互作用并竞争生脂基因的启动子来抑制PPARγ介导的转录活性。